Related Experiment Video
Updated: Feb 9, 2026

Ischemia-reperfusion Model of Acute Kidney Injury and Post Injury Fibrosis in Mice
Published on: August 9, 2013
Rifampicin in Nontuberculous Mycobacterial Infections: Acute Kidney Injury with Hemoglobin Casts
Rishi Kora1, Sergey V Brodsky2, Tibor Nadasdy2
1Mount Carmel West Hospital, Columbus, OH, USA.
Abstract:
Rifampicin is a key component of multidrug regimens not only for tuberculosis, but also nontuberculous mycobacterial infections (NTM) which are on the rise worldwide. Knowledge of the toxicity profile is important. Hepatotoxicity is a well-known side effect of Rifampicin necessitating regular liver function monitoring during therapy. Acute kidney injury (AKI) is a relatively rare complication, usually resulting from allergic interstitial nephritis (AIN). Rifampicin-induced intravascular hemolysis resulting in hemoglobinuria and AKI is even more uncommon, especially in Western countries with low prevalence of mycobacterial infections. Rifampicin-induced antibodies are implicated and this complication preferentially occurs during intermittent drug treatment protocols or when Rifampicin is restarted after a long drug-free interval. Awareness of this drug complication and its unique timing is important especially among emergency room physicians where patients with AKI may first present. It is equally important for nephrologists and pathologists. We describe one such case with detailed clinical course of the patient and interesting biopsy findings of ATN with intratubular hemoglobin casts.
Insights
Rifampicin can cause rare but serious kidney injury through intravascular hemolysis, particularly when treatment is intermittent or resumed after a break. Prompt recognition is crucial for patient outcomes.
Area of Science:
- Nephrology
- Pharmacology
- Pathology
Background:
- Rifampicin is essential for treating tuberculosis and rising nontuberculous mycobacterial (NTM) infections.
- Hepatotoxicity is a known Rifampicin side effect, requiring liver function monitoring.
- Acute kidney injury (AKI) from Rifampicin is rare, often linked to allergic interstitial nephritis.
Observation:
- This case highlights an uncommon Rifampicin complication: intravascular hemolysis leading to hemoglobinuria and AKI.
- This severe adverse event is particularly rare in Western countries.
- Antibody-mediated hemolysis is implicated, often occurring with intermittent Rifampicin therapy or upon re-initiation.
Findings:
- The patient presented with AKI, a serious complication of Rifampicin.
- Biopsy revealed acute tubular necrosis (ATN) with intratubular hemoglobin casts.
- This indicates Rifampicin-induced intravascular hemolysis as the cause of kidney injury.
Implications:
- Increased awareness of Rifampicin-induced hemolysis and AKI is vital for emergency physicians, nephrologists, and pathologists.
- Understanding the specific timing (intermittent or re-initiated therapy) is key for diagnosis.
- Early recognition and intervention can prevent severe kidney damage.
Related Concept Videos
Acute Kidney Injury I: Introduction
Acute Kidney Injury II: Pathophysiology
Acute Kidney Injury VI: Nursing Management
Acute Kidney Injury V: Interprofessional Care
Acute Kidney Injury III: Clinical Manifestations
Acute Kidney Injury IV: Diagnostic Studies and Prevention

